文献速递临床试验与 GCP流行病学与生物统计

算法指导治疗与常规治疗对葡萄球菌菌血症临床成功及严重不良事件的影响:一项随机临床试验

Effect of Algorithm-Based Therapy vs Usual Care on Clinical Success and Serious Adverse Events in Patients with Staphylococcal Bacteremia: A Randomized Clinical Trial.
PubMed 文献 · JAMA · 2018-01-01

该多中心随机试验纳入509例成人葡萄球菌菌血症患者,比较算法指导治疗与常规治疗。结果显示算法组临床成功率非劣效于常规组(82.0% vs 81.5%),严重不良事件率无显著差异(32.5% vs 28.3%),但置信区间较宽。在简单或非复杂性菌血症患者中,算法组抗生素疗程平均缩短1.8天。

要点

  • 算法指导治疗在葡萄球菌菌血症中临床成功率非劣效于常规治疗。
  • 两组严重不良事件发生率无显著差异,但置信区间宽,解释受限。
  • 算法组在简单或非复杂性菌血症中抗生素疗程平均缩短1.8天。

核心结论

  • 在葡萄球菌菌血症患者中,使用算法指导检测和治疗与常规护理相比,临床成功率非劣效。
  • 严重不良事件发生率无显著差异,但宽置信区间限制了结论的解释。

研究设计与样本

  • 研究为随机临床试验,在美国15个和西班牙1个学术医疗中心开展,共纳入509例成人葡萄球菌菌血症患者。
  • 患者随机分配至算法指导治疗组(n=255)或常规治疗组(n=254),随访至治疗结束后42天(金黄色葡萄球菌)或28天(凝固酶阴性葡萄球菌)。

主要发现

  • 临床成功在算法组为209/255(82.0%),常规组为207/254(81.5%),差异0.5%(单侧97.5%CI,-6.2%至∞)。
  • 严重不良事件发生率算法组32.5%,常规组28.3%,差异4.2%(95%CI,-3.8%至12.2%)。
  • 在符合方案分析的简单或非复杂性菌血症患者中,平均治疗时长算法组4.4天,常规组6.2天,差异-1.8天(95%CI,-3.1至-0.6)。

临床怎么用

  • 对于无复杂感染的葡萄球菌菌血症患者,可考虑采用算法指导治疗以缩短抗生素疗程。
  • 算法指导治疗未增加严重不良事件风险,但需关注宽置信区间带来的不确定性。

局限性

  • 严重不良事件率的置信区间较宽,限制了对安全性差异的解读。
  • 研究排除了已知或疑似复杂感染的患者,结论外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: The appropriate duration of antibiotics for staphylococcal bacteremia is unknown. OBJECTIVE: To test whether an algorithm that defines treatment duration for staphylococcal bacteremia vs standard of care provides noninferior efficacy without increasing severe adverse events. DESIGN, SETTING, AND PARTICIPANTS: A randomized trial involving adults with staphylococcal bacteremia was conducted at 16 academic medical centers in the United States (n = 15) and Spain (n = 1) from April 2011 to March 2017. Patients were followed up for 42 days beyond end of therapy for those with Staphylococcus aureus and 28 days for those with coagulase-negative staphylococcal bacteremia. Eligible patients were 18 years or older and had 1 or more blood cultures positive for S aureus or coagulase-negative staphylococci. Patients were excluded if they had known or suspected complicated infection at the time of randomization. INTERVENTIONS: Patients were randomized to algorithm-based therapy (n = 255) or usual practice (n = 254). Diagnostic evaluation, antibiotic selection, and duration of therapy were predefined for the algorithm group, whereas clinicians caring for patients in the usual practice group had unrestricted choice of antibiotics, duration, and other aspects of clinical care. MAIN OUTCOMES AND MEASURES: Coprimary outcomes were (1) clinical success, as determined by a blinded adjudication committee and tested for noninferiority within a 15% margin; and (2) serious adverse event rates in the intention-to-treat population, tested for superiority. The prespecified secondary outcome measure, tested for superiority, was antibiotic days among per-protocol patients with simple or uncomplicated bacteremia. RESULTS: Among the 509 patients randomized (mean age, 56.6 [SD, 16.8] years; 226 [44.4%] women), 480 (94.3%) completed the trial. Clinical success was documented in 209 of 255 patients assigned to algorithm-based therapy and 207 of 254 randomized to usual practice (82.0% vs 81.5%; difference, 0.5% [1-sided 97.5% CI, -6.2% to ∞]). Serious adverse events were reported in 32.5% of algorithm-based therapy patients and 28.3% of usual practice patients (difference, 4.2% [95% CI, -3.8% to 12.2%]). Among per-protocol patients with simple or uncomplicated bacteremia, mean duration of therapy was 4.4 days for algorithm-based therapy vs 6.2 days for usual practice (difference, -1.8 days [95% CI, -3.1 to -0.6]). CONCLUSIONS AND RELEVANCE: Among patients with staphylococcal bacteremia, the use of an algorithm to guide testing and treatment compared with usual care resulted in a noninferior rate of clinical success. Rates of serious adverse events were not significantly different, but interpretation is limited by wide confidence intervals. Further research is needed to assess the utility of the algorithm. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT01191840.

来源:JAMA,查看原文。版权归原作者所有。

引用

  1. Holland TL, Raad I, Boucher HW, et al. Effect of Algorithm-Based Therapy vs Usual Care on Clinical Success and Serious Adverse Events in Patients with Staphylococcal Bacteremia: A Randomized Clinical Trial. JAMA. 2018. PMID: 30264119. doi:10.1001/jama.2018.13155

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。